Auster Martin 4
4 · Ventyx Biosciences, Inc. · Filed Dec 19, 2023
Insider Transaction Report
Form 4
Auster Martin
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2023-12-18+181,250→ 181,250 totalExercise: $2.14Exp: 2033-12-18→ Common Stock (181,250 underlying)
Footnotes (1)
- [F1]One forty-eighth (1/48th) of the total shares subject to the Option shall vest each month following December 18, 2023 (the "Vesting Commencement Date") on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month), subject to the reporting person continuing to be a Service Provider, as defined in the Company's 2021 Equity Incentive Plan (the "Plan") through each such date.